{"id":1017663,"date":"2026-11-05T11:10:44","date_gmt":"2026-11-05T16:10:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/"},"modified":"2026-11-05T11:10:44","modified_gmt":"2026-11-05T16:10:44","slug":"corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/","title":{"rendered":"Corbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November"},"content":{"rendered":"
\n

NORWOOD, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview and meet with investors at the following conferences during the month of November:<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n Guggenheim 3<\/strong>
\n
\n rd<\/strong>
\n <\/sup>
\n Annual Healthcare Innovation Conference<\/strong>
\n \n <\/td>\n<\/tr>\n
Format:<\/td>\nPresentation and one-on-one investor meetings<\/td>\n<\/tr>\n
Date:<\/td>\nMonday, November 9, 2026<\/td>\n<\/tr>\n
Time:<\/td>\n8:00am EST<\/td>\n<\/tr>\n
Webcast:<\/td>\n\n Click here<\/a>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Jefferies Global Healthcare Conference<\/strong>
\n \n <\/td>\n<\/tr>\n
Format:<\/td>\nFireside Chat and one-on-one investor meetings<\/td>\n<\/tr>\n
Date:<\/td>\nWednesday, November 18, 2026<\/td>\n<\/tr>\n
Time:<\/td>\n9:00am GMT<\/td>\n<\/tr>\n
Webcast:<\/td>\n\n Click here<\/a>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n 9<\/strong>
\n
\n th<\/strong>
\n <\/sup>
\n Annual Evercore Healthcare Conference<\/strong>
\n \n <\/td>\n<\/tr>\n
Format:<\/td>\nFireside Chat and one-on-one investor meetings<\/td>\n<\/tr>\n
Date:<\/td>\nTuesday, December 1, 2026<\/td>\n<\/tr>\n
Time:<\/td>\n10:25am EST<\/td>\n<\/tr>\n
Webcast:<\/td>\n\n Click here<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

\n
Investors interested in meeting with Dr. Cohen should contact their representative.<\/p>\n

\n About Corbus<\/strong>\u00a0
Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage company focusing on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing innovative scientific approaches to well-understood biological pathways. Corbus\u2019 pipeline includes CRB-701, a next-generation antibody drug conjugate for the treatment of Nectin-4-expressing tumors, and CRB-913, an orally delivered highly peripherally restricted CB1 inverse agonist for the treatment of obesity. Corbus is headquartered in Norwood, Massachusetts. For more information on Corbus, visit\u00a0corbuspharma.com<\/a>. Connect with us on\u00a0X<\/a>,\u00a0LinkedIn<\/a>\u00a0and\u00a0Facebook<\/a>.<\/p>\n

\n Forward-Looking Statements
<\/strong>This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act of 1995, as amended, including those relating to the Company\u2019s trial results, product development, clinical and regulatory timelines, including timing for completion of trials and presentation of data, anticipated regulatory interactions and outcomes, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities, sufficiency of cash runway and other statement that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management\u2019s current beliefs and assumptions.<\/p>\n

These statements may be identified by the use of forward-looking expressions, including, but not limited to, \u201cexpect,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201cwould\u201d and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors on our operations, clinical development plans and timelines, which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company\u2019s filings with the Securities and Exchange Commission including those described in our Annual Report on Form 10-K for the year ended December 31, 2025. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.<\/p>\n

All product names, logos, brands and company names are trademarks or registered trademarks of their respective owners. Their use does not imply affiliation or endorsement by these companies.<\/p>\n

\n INVESTOR CONTACTS:<\/strong>
\n
Sean Moran
Chief Financial Officer
Corbus Pharmaceuticals
smoran@corbuspharma.com<\/a><\/p>\n

Dan Ferry
Managing Director
LifeSci Advisors, LLC
daniel@lifesciadvisors.com<\/a><\/p>\n

\n MEDIA CONTACT:<\/strong>
\n
Liz Melone
Founder & Principal
Melone Communications, LLC
liz@melonecomm.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NORWOOD, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview and meet with investors at the following conferences during the month of November: Guggenheim 3 rd Annual Healthcare Innovation Conference Format: Presentation and one-on-one investor meetings Date: Monday, November 9, 2026 Time: 8:00am EST Webcast: Click here \u00a0 \u00a0 Jefferies Global Healthcare Conference Format: Fireside Chat and one-on-one investor meetings Date: Wednesday, November 18, 2026 Time: 9:00am GMT Webcast: Click here \u00a0 \u00a0 9 th Annual Evercore Healthcare Conference Format: Fireside Chat and one-on-one investor meetings Date: Tuesday, December 1, 2026 Time: … <\/p>\n

Continue reading “Corbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1017663","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCorbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Corbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NORWOOD, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview and meet with investors at the following conferences during the month of November: Guggenheim 3 rd Annual Healthcare Innovation Conference Format: Presentation and one-on-one investor meetings Date: Monday, November 9, 2026 Time: 8:00am EST Webcast: Click here \u00a0 \u00a0 Jefferies Global Healthcare Conference Format: Fireside Chat and one-on-one investor meetings Date: Wednesday, November 18, 2026 Time: 9:00am GMT Webcast: Click here \u00a0 \u00a0 9 th Annual Evercore Healthcare Conference Format: Fireside Chat and one-on-one investor meetings Date: Tuesday, December 1, 2026 Time: … Continue reading "Corbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-05T16:10:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MDM1MiM3OTQ1OTE3IzUwMDExODg0MA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Corbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November\",\"datePublished\":\"2026-11-05T16:10:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\\\/\"},\"wordCount\":577,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MDM1MiM3OTQ1OTE3IzUwMDExODg0MA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\\\/\",\"name\":\"Corbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MDM1MiM3OTQ1OTE3IzUwMDExODg0MA==\",\"datePublished\":\"2026-11-05T16:10:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MDM1MiM3OTQ1OTE3IzUwMDExODg0MA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MDM1MiM3OTQ1OTE3IzUwMDExODg0MA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Corbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Corbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/","og_locale":"en_US","og_type":"article","og_title":"Corbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November - Market Newsdesk","og_description":"NORWOOD, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview and meet with investors at the following conferences during the month of November: Guggenheim 3 rd Annual Healthcare Innovation Conference Format: Presentation and one-on-one investor meetings Date: Monday, November 9, 2026 Time: 8:00am EST Webcast: Click here \u00a0 \u00a0 Jefferies Global Healthcare Conference Format: Fireside Chat and one-on-one investor meetings Date: Wednesday, November 18, 2026 Time: 9:00am GMT Webcast: Click here \u00a0 \u00a0 9 th Annual Evercore Healthcare Conference Format: Fireside Chat and one-on-one investor meetings Date: Tuesday, December 1, 2026 Time: … Continue reading \"Corbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-05T16:10:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MDM1MiM3OTQ1OTE3IzUwMDExODg0MA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Corbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November","datePublished":"2026-11-05T16:10:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/"},"wordCount":577,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MDM1MiM3OTQ1OTE3IzUwMDExODg0MA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/","name":"Corbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MDM1MiM3OTQ1OTE3IzUwMDExODg0MA==","datePublished":"2026-11-05T16:10:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MDM1MiM3OTQ1OTE3IzUwMDExODg0MA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MDM1MiM3OTQ1OTE3IzUwMDExODg0MA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences-in-november\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Corbus Pharmaceuticals to Participate\u00a0in Upcoming Investor Conferences in November"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1017663","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1017663"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1017663\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1017663"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1017663"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1017663"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}